Skip to main content
. 2017 Jan 31;8(9):15632–15641. doi: 10.18632/oncotarget.14921

Table 1. Association of COP-MPV with the clinicopathologic characteristics of patients with NSCLC.

Variables COP-MPV = 0 n(%) COP-MPV = 1 n(%) COP-MPV = 2 n(%) P value
Age (year) 0.890
 ≤60 62(52.1) 146(49.5) 66(50.0)
 >60 57(47.9) 149(50.5) 66(50.0)
Sex 0.004
 Female 53(44.5) 82(27.8) 48(34.1)
 Male 66(55.5) 213(72.2) 84(65.9)
Smoking 0.161
 Yes 70(58.8) 202(68.5) 89(67.4)
 No 49(41.2) 93(31.5) 43(32.6)
Tumor location 0.385
 Right 67(56.3) 173(58.6) 85(64.4)
 Left 52(43.7) 122(41.4.) 47(35.6)
Histological subtype 0.135
 Adenocarcinoma 58(48.7) 119(40.3) 43(32.6)
 SqCC 46(38.7) 137(46.4) 70(53.0)
 Others 15(12.6) 39(13.3) 19(14.4)
Lesion 0.411
 Peripheral 91(76.5) 213(72.2) 91(68.9)
 Central 28(23.5) 82(27.8) 41(31.1)
Resection type 0.860
 Pneumonectomy 14(11.8) 35(11.9) 18(13.6)
 Lobectomy 105(88.2) 260(88.1) 114(86.4)
Lymph node metastasis 0.810
 Yes 51(42.9) 136(46.1) 58(43.9)
 No 68(57.1) 159(53.9) 74(56.1)
Pathological stage <0.001
 I 55(46.2) 141(47.8) 40(30.3)
 II 32(26.9) 32(10.8) 49(37.1)
 IIIA 32(26.9) 122(41.4) 43(32.6)

Abbreviations: COP-MPV, combination of preoperative platelet count and mean platelet volume; NSCLC, non-small cell lung cancer; SqCC, Squamous cell carcinoma.

P less than .05 is statistically significant.